News

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain.
Second-quarter adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, beating expectations.
RFK Jr cancels $500m in funding for mRNA vaccines for diseases like Covid
The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...
Buy Pfizer Stock At $24?
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
PhillyVoice15h
Technology advanced by Penn scientists led to COVID shots. Five years later, RFK Jr. is slashing mRNA vaccine research
The Health and Human Services secretary cancelled nearly $500 million in contracts related to the development of future ...
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Pfizer stock pops as big pharma giant delivers post-COVID comeback
Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.
1 Reason to Buy Pfizer (PFE) Stock
And better still, healthy and growing dividend-paying stocks tend to increase their payouts over time. Pfizer's total annual ...
MedPage Today on MSN2d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season?
The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
USA Today3y
When will kids get COVID vaccine? Your Pfizer questions, answered.
Pfizer’s clinical trials in children 5 to 11 did not measure the vaccine’s effectiveness against COVID-19. Effectiveness was “never the intended primary endpoint,” Anderson said.
HHS phases out mRNA vaccine trials for COVID-19, bird flu
HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...